US 10391075
Antiviral treatments
granted A61KA61K31/195A61K31/196
Quick answer
US patent 10391075 (Antiviral treatments) held by BioCryst Pharmaceuticals, Inc. expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/195, A61K31/196, A61K31/215, A61K45/06